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ABSTRACT Overexpression of HER2, a receptor-like tyrosine kinase and signaling partner for the epidermal growth factor
receptor (EGFR), has been implicated in numerous experimental and clinical studies as promoting the progression of many
types of cancer. One avenue by which HER2 overexpression may dysregulate EGFR-mediated cell responses, such as
proliferation and migration, downstream of EGF family ligand binding, is by its modulation on EGFR endocytic trafﬁcking
dynamics. EGFR signaling is regulated by downregulation and compartmental relocalization arising from endocytic
internalization and endosomal sorting to degradation versus recycling fates. HER2 overexpression inﬂuences both of these
processes. At the endosomal sorting stage, increased HER2 levels elicit enhanced EGFR recycling outcomes, but the
mechanism by which this transpires is poorly understood. Here, we determine whether alternative mechanisms for HER2-
mediated enhancement of EGFR recycling can be distinguished by comparison of corresponding mathematical models to
experimental literature data. Indeed, we ﬁnd that the experimental data are clearly most consistent with a mechanism in which
HER2 directly competes with EGFR for a stoichiometrically-limited quantity of endosomal retention components (ERCs),
thereby reducing degradation of ERC-coupled EGFR. Model predictions based on this mechanism exhibited qualitative trends
highly similar to data on the fraction of EGF/EGFR complexes sorted to recycling fate as a function of the amount of internalized
EGF/EGFR complexes. In contrast, model predictions for alternative mechanisms—blocking of EGFR/ERC coupling, or altering
EGF/EGFR dissociation—were inconsistent with the qualitative trends of the experimental data.
INTRODUCTION
Elevated expression of the epidermal growth factor receptor
(EGFR) and/or human epidermal growth factor receptor 2
(HER2) has been implicated in the development of cancer by
contributing to aberrant cell behavior including increased
motility, increased sensitivity to mitogenic stimuli, anchor-
age independence, and cell transformation (Brandt et al.,
1999; Chazin et al., 1992; DiFiore et al., 1987a,b; Ignatoski
et al., 1999; Spencer et al., 2000). The quantity and in-
tracellular localization of these receptors is able to in-
ﬂuence cell behavior by dictating both the strength and
quality of signals generated. Thus, understanding the reg-
ulatory mechanisms involved in controlling the number of
EGFR and/or HER2 is of prime importance in dissecting
how elevated receptor expression is able to alter cell sig-
naling that manifests itself in tumorigenesis.
After EGF binding, the EGFR family of receptor protein
tyrosine kinases (EGFR, HER2, HER3, and HER4) interact
and transphosphorylate to form a wide array of homo- and
heterodimers, each with distinct signaling abilities (Alroy
and Yarden, 1997; Muthuswamy et al., 1999; Olayioye et al.,
1998; Yarden and Sliwkowski, 2001). Activated receptors
recruit cascades of intracellular signaling molecules, in-
cluding members of the Ras/MAPK and PLC-g pathways
that control a diverse range of cell responses. The signals that
are recruited depend heavily on receptor location. For
example, PLC-g, calpain, and Grb2, are primarily activated
or recruited by surface EGFR, while Eps8 is associated with
only intracellular receptors and the Ras pathway may be
activated by both surface and intracellular EGFR (Burke
et al., 2001; Glading et al., 2001; Haugh et al., 1999a,b).
Signaling through EGFR is negatively regulated via
intracellular trafﬁcking (Sorkin and Waters, 1993; Wiley
and Burke, 2001), a process that attenuates growth factor
signaling via both the short- and long-term downregulation
of receptor number. Overexpression or mutation of the
EGFR has been shown to impair downregulation, as
a consequence of altered trafﬁcking, indicating the impor-
tance of proper trafﬁcking for the normal regulation of cell
growth (Vieira et al., 1996; Wells et al., 1990).
EGF binding initiates the rapid internalization of EGF-
EGFR complexes via clathrin-coated-pit endocytosis to early
endosomal compartments. This process can be saturated in
cases where surface complex number exceeds the capacity of
the adaptor proteins involved in receptor-mediated endocy-
tosis (Lund et al., 1990; Wiley, 1988). Dimerization with
other EGFR family members is also thought to slow this
process as HER2, HER3, and HER4 all exhibit some degree
of endocytic impairment (Baulida et al., 1996; Hendriks
et al., 2003b; Sorkin et al., 1993; Wang et al., 1999).
After internalization, occupied EGFR have been shown to
be selectively retained within the endosome, whereas empty
receptors follow the default recycling pathway back to
the surface (French et al., 1994; Herbst et al., 1994). The
endosomal retention of occupied receptors has been demon-
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strated to be both speciﬁc and saturable, requiring cytoplas-
mic sequences for efﬁcient retention and lysosomal target-
ing, but independent of intrinsic tyrosine kinase ability
(French et al., 1994; Herbst et al., 1994; Opresko et al., 1995;
Wiley et al., 1991). The selective retention of occupied
EGFR is mediated through via a di-leucine motif in the
juxtamembrane region (Kil and Carlin, 2000; Kil et al.,
1999). Two regions of the EGFR, residues 1022–1063 and,
to a lesser extent, 1063–1123, are believed to contribute in
targeting receptors to the degradation pathway (Kornilova
et al., 1996). Additionally, EGFR residues 943–957 are
known to interact with SNX1, a putative endosomal sorting
protein believed to be involved in targeting EGFR to
degradative fates (Kurten et al., 1996; Zhong et al., 2002).
EGFR deactivation and degradation also vary with the
sorting behavior of different ligands (EGF vs. TGF) (French
et al., 1995).
Ligand stimulus also results in EGFR-mediated phos-
phorylation of c-Cbl, a protein involved in the ubiquitization
and degradation of EGFR. Overexpression of c-Cbl en-
hances ubiquitination and degradation of EGFR, whereas
oncogenic viral Cbl interferes with the sorting function of
c-Cbl, directing EGFR to recycling fates (Levkowitz et al.,
1999, 1998). Interestingly, c-Cbl does not interact with other
EGFR family members, including HER2 (Levkowitz et al.,
1996).
HER2 is an almost ubiquitously expressed EGFR family
member that does not bind any ligands and therefore must
rely on dimerization with another EGFR family member for
complete activation (Graus-Porta et al., 1997; Hynes and
Stern, 1994; Karunagaran et al., 1996; Worthylake and
Wiley, 1997). Overexpression of HER2 has been demon-
strated to inhibit downregulation of the EGFR and of itself,
as well as increase the recycling rate of EGF (Hendriks et al.,
2003a; Worthylake et al., 1999). HER2 expression has been
shown to shunt ligand-activated receptors to recycling fates
suggesting that receptor heterodimer species may have
a superior signaling potency as a consequence of their
intracellular routing (Lenferink et al., 1998; Waterman et al.,
1998). Receptor heterodimerization has been shown to affect
the dissociation rate of EGF or heregulin and may also do so
inside of endosomal compartments (Karunagaran et al.,
1996; Lenferink et al., 1998; Lewis et al., 1996; Wada et al.,
1990). Although it is apparent that HER2 expression inﬂuen-
ces the endosomal sorting of EGF and EGFR, the dominant
mechanism(s) by which it occurs remain unclear.
Theoretical models of endosomal sorting have examined
the biophysical requirements for molecular transport out of
a central endosomal vesicle into recycling tubules and
spawned the development of a mechanistic model (French
and Lauffenburger, 1996; Lauffenburger and Linderman,
1993; Linderman and Lauffenburger, 1986). In this model,
the endosomal sorting of the EGFR and its ligands were
mathematically modeled using a compartmental analysis
incorporating endosomal retention components (ERCs) and
a representation of endosomal architecture. By detailing
the mechanistic and biophysical basis for endosomal sort-
ing, one uniﬁed model is able to account for a wide range
of experimentally observed sorting results. However, this
model does not account for the effects of HER2 on EGF
sorting.
The goal of this work is to build upon the French ERC
model of sorting to understand how different EGFR and
HER2 interactions could contribute to qualitative trends in
experimental sorting curves. Speciﬁcally, we seek to dis-
criminate between three different mechanisms by which
HER2 may disrupt the sorting process through the compari-
son of experimental and modeling outcomes. Our results
suggest that HER2 is able to alter EGF sorting primarily
through a competitive mechanism wherein it competes for
a limited number of ERCs, rather than by blocking EGF-
EGFR interaction with ERCs or by altering the afﬁnity of
EGF.
MODEL DEVELOPMENT
Our model of endosomal sorting is an extension of the
mechanistic sorting model based on ERC sorting model
originally proposed by French and Lauffenburger (1996).
We add HER2 to the model and consider three distinct
mechanisms by which HER2 interaction may augment EGF
sorting.
The framework of the ERC sorting model is brieﬂy
presented here; its development, assumptions, and validation
are explained in detail elsewhere (French and Lauffenburger,
1996, 1997). This model (illustrated schematically in Fig. 1)
simulates the quasi-steady-state sorting of EGFRs (R1) and
ligands (L) as they pass through the endosomal pathway. The
cell interior is separated into four compartments: an endo-
somal vesicular compartment (v), an endosomal tubular
compartment (t), a postsorting recycling compartment (r),
and a postsorting degradation compartment (d). Ligand may
bind to receptors to form complexes and subsequently
dissociate at rates kon and koff, respectively. Internalized
ligand-receptor complexes (R1L) enter the vesicular com-
partment of the endosome. Within the vesicular compart-
ment, complexes and unoccupied receptors may diffuse into
the tubular compartment with transport rate g. Complexes
may interact with ERCs (E), at rate kc,R1E (or at rate kc,R1E,het
for the case of heterodimers), in the vesicular compartment to
form ternary complexes (R1LE) which have a negligible rate
of transport into the tubular compartment. ERCs only bind
occupied receptors; their total quantity is assumed to be at
steady state, and all ERC-containing species are restricted to
the vesicular compartment of the endosome. Ligands may
dissociate from ternary complexes at rate koff leaving binary
complexes (R1E) that either rebind ligand at rate kon or
uncouple at rate ku,R1E to form free receptors and ERCs. Free
ligand may bind unoccupied receptors at rate kon and is
assumed to be in equilibrium between the tubular and
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FIGURE 1 (A) Endosomal sorting model, proposed by French and Lauffenburger. The cell is divided into four compartments: endosomal vesicle,
endosomal tubule, recycling, and degradation compartments. Internalized ligand-receptor complexes enter vesicular compartment where they diffuse into the
tubular compartment or are selectively retained in the central vesicle by ERCs. The vesicular compartment of the endosome targets species for degradation
while the tubular compartment of the endosome targets species for recycling. (B) Within endosome, occupied EGFR (Y-shaped species) are selectively retained
in vesicular portion by interaction with ERCs (solid pentagons). Species not bound by ERCs are free to diffuse into tubular compartments for recycling. (C)
Additional receptor interactions are added as a result of HER2 (T-shaped species) presence. HER2 may dimerize with occupied EGFRs. EGF may dissociate
from receptor heterodimers yielding unoccupied heterodimers which instantaneously break apart into unoccupied EGFR and free HER2. (D) The addition of
HER2 to the model drives the formation of heterodimers and shifts the model input from 100% EGF-EGFR complexes to a combination of complexes and
heterodimers to 100% heterodimers.
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vesicular lumen, related by partition coefﬁcient, k, account-
ing for excluded volume due to ligand size. Vesicular
receptor and ligand species are targeted for the postsorting
degradation compartment at rate ksv, whereas tubular
receptor and ligand species are targeted for the postsorting
recycling compartment at rate kst. The input into the model is
the ﬂux of ligand-receptor complexes (IR1L).
The general changes brought about by HER2 presence are
presented here and the details unique to each model follow
below (Fig. 1 c). The addition of HER2 to the sorting model
adds a few additional species. Free HER2 (R2) is permitted
to heterodimerize with occupied EGFR at rate kc to form
occupied heterodimers (R1LR2) and uncouple at rate
ku,R1LR2. Free HER2 and occupied heterodimers move from
the vesicular compartment to the tubular compartment at
transport rate g. Ligand may dissociate from heterodimers at
rate koff,het. Unoccupied heterodimers are assumed to be
sufﬁciently unstable that they instantaneously break apart to
yield free EGFR and free HER2. The input to the model
consists of the ﬂux of ligand-receptor complexes (IR1L), as
well as the ﬂux of occupied heterodimers (IR1LR2), as
cartooned in Fig. 1 d. Elevated HER2 expression drives the
formation of heterodimers and shifts the model input from
100% EGF-EGFR complexes to a combination of complexes
and heterodimers to 100% heterodimers. The interactions
between free HER2 and heterodimers with ERCs are unique
to each model, and presented below.
Wepropose three distinct, although notmutually exclusive,
mechanisms by which HER2 may disrupt the normal
endosomal sorting of EGF and the EGFR. Each mechanism
is considered separately for clarity and ease of interpretation.
The complete set of equations encompassing all models is
listed in the Appendix.
Blockade model
In this model, we propose that EGF-EGFR complex
heterodimerization with HER2 may impair EGFR interaction
with ERCs, cartooned in Fig. 2 a. When in the hetero-
dimerized state, complexes are no longer able to bind ERCs
(kc,R1E,het is set to zero). As such, HER2 is able to block the
selective endosomal retention of EGF-EGFR complexes.
Competition model
Here, in addition to occupied EGFR, both free HER2 and
HER2 that is heterodimerized with EGFRs can bind ERCs.
All HER2-containing species bind ERCs at rate kc,R2E or
kc,R2E,het to form speciesR2EorR1LR2E orER1LR2E (depen-
ding on whether HER2 has heterodimerized and whether the
EGF-EGFRcomplex has anERCbound or not), and uncouple
at rate ku,R2E. The model is cartooned in Fig. 2 b.
Afﬁnity model
In this model, EGF-EGFR complex heterodimerization with
HER2 alters the endosomal afﬁnity of EGF for its receptor
by altering its rate of dissociation from heterodimers (koff,het
is different from koff). The presence of HER2 and
heterodimerization does not affect the ability of occupied
EGFR to bind ERCs and HER2 does not bind ERCs itself.
This model is cartooned in Fig. 2 c.
Model inputs
The input to the model is a speciﬁed ﬂux of ligand-receptor
complexes (IR1L) and the ﬂux of ligand-bound heterodimers
(IR1LR2) (see Fig. 1 d ). These parameters represent the rates
of complex and heterodimer internalization, respectively.
Although the internalization rate and the number of surface
receptors has experimentally been shown to vary with ligand
concentration and time, internalization ﬂuxes are held
constant for simplicity so that the effects on endosomal
sorting may be isolated from effects due to differences in
internalization (Wiley et al., 1991).
FIGURE 2 (A) Blockade model. Heterodimerization with HER2 prevents
EGFR-ERC and (EGF-EGFR)-ERC interaction. (B) Competition model.
HER2 competes with EGFR for ERC interaction. Both free and
heterodimerized HER2 species may interact with ERCs. (C) Afﬁnity model.
EGF-EGFR heterodimerization with HER2 alters the dissociation rate of
EGF.
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An increase in HER2 expression level should result in
a higher degree of EGF-EGFR/HER2 heterodimerization by
simple mass action kinetics. When no HER2 is present, the
model input is only IR1L (with IR1LR2 set to 0). In the other
extreme, when HER2 is in great excess, the model input is
only IR1LR2 (with IR1L set to 0). The cases in between, where
neither ke,R1L nor ke,R1LR2 are 0, reﬂect modest degrees of
heterodimerization and directly reﬂect the receptor expres-
sion levels and their afﬁnities for homo- versus heterodime-
rization.
Parameter determination
While there exists a great deal of cellular data and rate
constants in the literature, it is scattered across many cell
types. Because of this we have chosen to adopt the
physiological reasonable parameters values, based on the
ranges used in the original ERC sorting model, shown in
Tables 1 and 2. The uncoupling rate of occupied hetero-
dimers (ku,R1LR2) is estimated based on previous work and is
set to 0.1 min1 (Hendriks et al., 2003b). Parameters with no
estimate or those believed to be of particular importance in
determining the system output (ku,R1LR2, ku,R2E, and koff,het)
are varied over wide ranges as shown in Results. A complete
list of parameter values are shown in Tables 1 and 2.
Computations
All model equations are simultaneously coded into Matlab,
ver. 6.5 (Mathworks, Natick, MA) and solved at steady state.
Individual models are examined by setting appropriate
parameters to zero and/or varying parameters of interest
before evaluation. Each simulation is run with a speciﬁed
ﬂux of ligand-receptor complexes and occupied hetero-
dimers. After 120 min of simulation time, when steady state
has been reached, sorting fractions and intracellular ligand
concentrations were determined as described in Results. By
varying the magnitude of the input ﬂuxes of ligand-receptor
complexes and occupied heterodimers, holding their ratio
constant, sorting curves relating sorting fraction to in-
tracellular ligand concentration were generated.
RESULTS
Experimental sorting outcomes
The motivation for this work comes from the experimental
observations of the endosomal sorting of EGF as a function
TABLE 1 Parameter values used in endosomal sorting model
that are common to all models
Parameter Description Base value
Nav Avogadro’s number 6.023 3 10
23 #/mol
Vtotal Total endosomal volume 3 3 10
14 L
h Ratio of volume in tubular
compartments to vesicular
compartments
0.67
kst Tubular sorting rate constant 0.53 min
1
ksv Vesicular rate constant 0.06 min
1
k Partition coefﬁcient
accounting for
excluded volume in
tubules due to ligand size
0.81
j Fraction of internalized ligand
nonspeciﬁcally endocytosed
0
g Transport rate constant of
receptors out of vesicular
compartment into tubular
compartment
1 min1
kh Degradation rate constant 0.09 min
1
kx Recycling rate constant 0.15 min
1
kon EGF binding rate constant 5 3 10
7 M1 min1*
koff EGF dissociation rate
constant from EGFR
0.5 min1*
kc EGF-EGFR/HER2
dimerization rate constant
1 3 103
(#/cell)1 min1
ku,R1LR2 EGF-EGFR/HER2
uncoupling rate constant
0.1 min1y
kc,R1E EGF-EGFR/ERC
coupling rate constant
1 3 103
(#/cell)1 min1
ku,R1E EGFR-ERC uncoupling
rate constant
0.1 min1
ERCtotal Total number of ERCs 10,000 #/cell
IR1L Input ﬂux of
EGF-EGFR complexes
Varied
IR1LR2 Input ﬂux of
EGF-EGFR/HER2
Varied
All values come from the original ERC sorting model (French and
Lauffenburger, 1996), except as noted.
*Experimentally measured (data not shown).
yParameter value from Hendriks et al. (2003a).
TABLE 2 Parameter values that are speciﬁc to individual models
Value
Parameter Description Blockade model Competition model Afﬁnity model
koff_het EGF dissociation rate constant from
heterodimers
0.5 min1 0.5 min1 0.1–2.5 min1
kc,R1E,het EGF-EGFR/ERC coupling rate
constant when in a heterodimer
0 1 3 103 (#/cell)1 min1 1 3 103 (#/cell)1 min1
kc,R2E HER2/ERC coupling rate constant 0 1 3 10
3 (#/cell)1 min1 0
kc,R2E,het HER2/ERC coupling rate constant
when in a heterodimer
0 1 3 103 (#/cell)1 min1 1 3 103 (#/cell)1 min1
ku,R2E HER2/ERC uncoupling rate constant 0 0.1 min
1 0
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of HER2 expression level originally published in Hendriks
et al. (2003a) (reprinted in Fig. 3 a). These results describe
steady-state sorting outcomes for 184A1 human mammary
epithelial cells for varying EGF concentrations as a function
of HER2 expression level. Each cell clone shown has
a comparable level of EGFR expression (;2 3 105) and
HER2 expression levels of 3 3 104 and 6 3 105 for the
parental line, and HER2 clone 24H, respectively (Hendriks
et al., 2003a). In the parental cell line, increasing intracellular
EGF resulted in a downward slope in the fraction of EGF
recycled. This is consistent with other work demonstrating
the selective retention of EGF-EGFR complexes within the
endosome (French et al., 1994). Elevated HER2 expression,
as seen in clone 24H, demonstrated an increase in the
fraction of EGF recycled relative to the parental cell line. The
shallow positive relationship between intracellular EGF and
the fraction of EGF recycled for clone 24H suggests that the
endosomal cargo is starting to exceed the capacity of the
sorting apparatus.
In addition, the role of heterodimerization was examined
in steady-state sorting experiments after overnight pre-
treatment with saturating amounts (10 mg/ml) of monoclonal
antibody 2C4. 2C4 binds to an extracellular epitope on
HER2 and has been shown to block both its transactivation
and heterodimerization with the EGFR (Agus et al., 2002;
Baselga, 2002; Fendly et al., 1990; Lewis et al., 1996). As
shown in Fig. 3 b (reprinted from Hendriks et al., 2003a),
blocking heterodimerization was sufﬁcient to reverse effect
of elevated HER2 expression on sorting fraction. The sorting
curve for HER2 clone 24H after 2C4 treatment closely
resembled that of the parental cell line. As expected, the
addition of 2C4 had no effect on sorting for the parental cell
line (Hendriks et al., 2003a).
Sorting fractions
The degree to which internalized ligands are recycled toward
the surface versus targeted for endosomal degradation can be
described by a sorting fraction. This fraction represents the
ratio of ligand molecules that leave the endosomal tubules
and enter the recycling compartment to the total amount of
ligand molecules that leave the endosomes through either the
tubular or vesicular compartment and enter the recycling or
degradative compartments, respectively. Ligand molecules
may transit through the system either as unbound ligand
that is free in the endosomal lumen or as bound ligand
that is complexed with EGFR in the form of receptor-
ligand complexes or as part of a bound EGF-EGFR/HER2
heterodimer.
When the sorting process is at steady state, the sorting
fractions can be deﬁned as follows:
fx ¼ kstðLB;t1 LF;tÞ=ðkstðLB;t1 LF;tÞ1 ksvðLB;v1 LF;vÞÞ;
with
LF;t ¼ hkLvVvNA
LB;t ¼ R1Lt1R1LR2t
LF;v ¼ LvVvNA
LB;v ¼ R1Lv1R1LEv1R1LR2v; for the blockademodel
¼ R1Lv1R1LEv1R1LR2Ev1ER1LR2v;
for the competitionmodel
¼ R1Lv1R1LEv1R1LR2v1ER1LR2v;
affinity model;
where kst is the tubular sorting rate constant; ksv is the
FIGURE 3 Experimental EGF sorting data. (A) Fraction of EGF recycled
as a function of intracellular EGF concentration for cell lines expressing
increasing levels of HER2 (reprinted from Hendriks et al., 2003a). Circles
and squares represent the parental cell line and HER2 clone 24H, expressing
roughly 3 3 104 and 6 3 105 HER2 per cell, respectively. (B) Addition of
heterodimerization-blocking antibodies (2C4) abrogates HER2 effect on
EGF recycling. Steady-state sorting assays were conducted with (open
symbols), or without (solid symbols), overnight pretreatment of saturating
amounts of 2C4 antibody on the parental cell line (circles), and HER2 clone
24H (squares).
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vesicular sorting rate constant; LF,i and LB,i are the free and
bound ligand concentrations in compartment i, respectively;
where compartment i is either the tubular (t) or vesicular (v)
compartment of the endosome; Vv is the vesicular volume;
NA is Avogadro’s number; R1Li is the concentration of
ligand-receptor complexes (#/cell) in compartment i; R1LR2i
is the concentration of ligand bound heterodimers in
compartment i; R1LEv is the concentration of ternary
ligand-receptor-endosomal retention component complexes;
and ER1LR2v and R1LR2Ev are bound heterodimers with an
ERC bound to the EGFR or HER2, respectively.
The differences in the deﬁnitions of the sorting fraction for
each model directly reﬂect each model’s construction. Since
the differences in each model lie only in the receptor inter-
actions allowed, the expression for free ligand concentration
is identical in each case. For each model the bound ligand in
the tubular compartment consists of all ligand bound species
allowed (R1Lt andR1LR2t). The bound ligand in the vesicular
compartment consists of all ligand-bound species allowed by
the model including those that contain ERCs.
For comparisonwith experimental results, sorting fractions
are plotted as a function of total intracellular ligand concen-
tration at steady state. Examination of steady state sorting
helps to decouple recycling from the effects of internalization.
Total intracellular ligand concentration (Ci) is given by
Ci ¼ LF;t1 LF;v1 LF;r1 LF;d1 LB;t1 LB;v1 LB;r1 LB;d;
where the intracellular ligand concentration is the sum of the
free (F) and bound (B) ligands in each compartment, and the
tubular (t), vesicular (v), recycling (r), and degradation (d)
compartments.
ERC sorting model fundamentals
From a foundation of previous modeling efforts, we have
a useful basis for understanding of how different experi-
mental outcomes reﬂect various molecular-level interactions
in the sorting process (French and Lauffenburger 1996,
1997). The typical sorting curve can be broken into three
regimes (see French and Lauffenburger, 1996), as shown
in Fig. 4. In regime I, at low intracellular EGF, sorting
outcomes are the result of ﬂuid phase sorting. The majority
of ligands dissociate from their receptors and the recycling
fraction reﬂects the ﬂuid phase partitioning of ligands
between the endosomal lumen and recycling tubules. In
regime II, at intermediate EGF concentration, occupied re-
ceptors are selectively retained by ERCs and targeted for
degradation; hence, the downward slope of the sorting curve.
FIGURE 4 Typical sorting curve from the original ERC sorting model.
The curve can be broken into three regimes: I, ﬂuid-phase sorting; II, EGFR
complex interaction with ERCs, decreasing the fraction of EGF recycled;
and III, saturation of a limited quantity of ERCs. Experimental data shown in
Fig. 3 fall primarily within regime II as indicated by the rectangle.
FIGURE 5 Simulated sorting curves for the blockade model, in which
heterodimerization blocks EGFR/ERC interaction. (A) Model input is varied
from 100% EGF-EGFR complexes/0% heterodimers (solid line), to 50%
EGF-EGFR complexes/50% heterodimers (dot-dashed line), to 0% EGF-
EGFR complexes/100% heterodimers (dotted line). (B) Bound heterodimer
uncoupling rate constant (ku,R1LR2) is varied from 0.1 to 1003 the base value
(0.1 min1), for a model input of 0% EGF-EGFR complexes/100%
heterodimers.
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Here, endosomal ligand concentration is high enough to
force receptor occupancy, but low enough so that the ERCs
are not saturated. In regime III, at high intracellular EGF, the
ERCs become saturated and there is a sharp increase in
fraction recycled, reﬂecting the fact that recycling is the
default pathway for the EGFR (French et al., 1994). It should
be noted that experimental results usually do not contain all
three regimes due to limitations in 125I-EGF detection and/or
limitations at the level of internalization, including limited
internalization capacity and/or EGFR number. Based on the
experimental data, it is apparent that the parental cell line
falls entirely within regime II, whereas clone 24H displays
the onset of saturation, as seen in the beginning of regime III.
The area of interest for our experimental data is outlined in
Fig. 4. All further model results will focus within this region.
Blockade model
Some recent experimental work has indicated potential
differential signaling abilities of heterodimers versus homo-
dimers. Controlled homo- and heterodimerization of EGFR
and HER2 has shown that heterodimerization with HER2
impedes the ability of the EGFR to recruit c-Cbl, possibly by
failing to phosphorylate a key tyrosine residue on the
cytoplasmic domain of the EGFR (Muthuswamy et al.,
1999). In this model, we propose that EGF-EGFR complex
heterodimerization with HER2 may impair EGFR interaction
with ERCs (see Fig. 2 a). Fig. 5 a illustrates how the sorting
fraction of EGF is predicted to change for the blockade
model as the input ratio is varied from 100% EGF-EGFR
complexes to 100% heterodimers.
As the ratio of heterodimers to complexes increases, there
is an immediate effect on the sorting fraction, particularly at
low intracellular ligand concentrations. An input of 100%
heterodimers elicits an increase in sorting fraction of up to 0.4
when compared to an input of 100% complexes, at an intra-
cellular ligand concentration of only 104 #/cell. In the regime
before ERC saturation, the entire curve is shifted upward so
that the effect of adding HER2 to the system is immediate and
is readily observed. In this model, a single molecule of HER2
is able to elicit a direct difference in sorting fraction, parti-
cularly at low intracellular EGF concentrations.
Effects of the basic parameters of the original endosomal
sorting model have already been explored in detail (French
and Lauffenburger, 1996, 1997). As such, we constrain
ourselves to examination of the parameters whose response
is affected as a consequence of HER2 expression. In
particular, the effect of HER2 expression on endosomal
sorting can be modulated by changes in the afﬁnity for
heterodimerization. As many of the membrane-level receptor
interactions are likely to be diffusion-limited, we choose to
examine changes in heterodimerization afﬁnity by altering
the heterodimer uncoupling rate (ku,R1LR2) (Shea et al.,
1997). As shown in Fig. 5 b, using a model input of 100%
heterodimers, a decrease in the heterodimer uncoupling rate
increases the efﬁciency with which a given HER2 expression
level is able to enhance EGF sorting toward recycling.
Competition model
Based on the high degree sequence similarity of the
cytoplasmic domains of the EGFR and HER2 it is possible
that the presence of HER2 may compete with the EGFR
for interaction with ERCs (Earp et al., 1995; Schechter
et al., 1985; Ullrich et al., 1984). In this model’s construc-
tion, both free HER2 and HER2 that is heterodimerized with
EGFRs can bind ERCs. Consequently, HER2 competes
with the EGFR for a limited quantity of available ERCs (see
Fig. 2 b), accelerating the onset of saturation of endosomal
sorting.
FIGURE 6 Simulated sorting curves for the competition model, in which
both free and heterodimerized HER2 competes with EGFR for interaction
with ERCs. (A) Model input is varied from 100% EGF-EGFR complexes/
0% heterodimers (solid line), to 50% EGF-EGFR complexes/50%
heterodimers (dot-dashed line), to 0% EGF-EGFR complexes/100%
heterodimers (dotted line). (B) HER2/ERC uncoupling rate constant (ku,R2E)
is varied from 0.1 to 1003 the base value (0.1 min1), for a model input of
0% EGF-EGFR complexes/100% heterodimers.
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Fig. 6 a shows the predicted effect of increasing HER2
expression level on the endosomal sorting of EGF-EGFR
complexes when HER2 competes for interaction with
ERCs. The model input is varied from 100% EGF-EGFR
complexes to 50% EGF-EGFR complexes, 50% hetero-
dimers to 100% heterodimers. At very low intracellular
EGF concentrations (\103 #/cell) the three curves merge
and are indistinguishable (not shown on graph). As
intracellular EGF increases, the curves diverge and ulti-
mately converge again (this portion is not shown on the
graph) as the sorting machinery becomes saturated. HER2
expression has its greatest impact just before ERC
saturation at intermediate intracellular EGF concentrations
(;104 #/cell). At this EGF concentration, an input of
100% heterodimers elicits an increase in sorting fraction of
;0.1 over that of an input of 100% complexes. The
addition of HER2 accelerates the onset of saturation of the
sorting machinery by effectively titrating out the number
of ERCs. Consequently, at low EGF concentrations, where
the number of ERCs greatly exceeds the number of
internal receptors, HER2 is unable to induce any effect on
EGF sorting.
In this model, the system interaction is governed by the
afﬁnities of HER2 and EGF-EGFR complexes for ERCs. For
a model input of 100% heterodimers, decreasing the HER2/
ERC uncoupling rate resulted in an increase in sorting
fraction (Fig. 6 b). Thus, increasing the expression of HER2
has the same effect as decreasing the HER2/ERC uncoupling
rate.
Afﬁnity model
The endosomal sorting of ligands is strongly controlled by
their binding properties at endosomal pH. There are many
reports of HER2 increasing EGFR afﬁnity for EGF by as
much as sixfold (Karunagaran et al., 1996; Lenferink et al.,
1998; Lewis et al., 1996; Wada et al., 1990; Worthylake
et al., 1999). Under certain conditions, heightened EGF
afﬁnity within the endosome has been shown to enhance
ligand recycling (French and Lauffenburger 1996).
Conversely, Lenferink and co-workers demonstrated an
increase in EGF dissociation from heterodimers at endo-
somal pH (Lenferink et al., 1998). The increased dissociation
of TGFa at pH 6.0, relative to EGF, results in an increase in
recycling (French et al., 1995). Thus, it is conceivable that
EGF-EGFR heterodimerization with HER2 may increase
EGF recycling by promoting the dissociation of EGF from
EGFR.
In this model, EGFR/HER2 heterodimerization acts to
alter the dissociation rate of EGF from the EGFR (see Fig. 2
c). Two cases are considered. In the ﬁrst case we consider the
possibility that heterodimerization increases the dissociation
rate of EGF, modeled by an increased dissociation rate from
0.5 to 2.5 min1. Secondly, we consider the case where
heterodimerization enhances EGFR afﬁnity for EGF,
modeled by a dissociation rate decreased from 0.5 to 0.1
min1. HER2 does not interact with ERCs, and hetero-
dimerization does not affect the ability of the EGFR to bind
ERCs whereas EGF is still bound. Similar to the blockade
model, altering EGF dissociation results in an immediate
effect on EGF sorting such that the entire sorting curve (in
the regime before saturation) is shifted up in the case where
the dissociation rate is increased (Fig. 7 a) and is shifted
down in the case where the dissociation rate is decreased
(Fig. 7 b). Given the relatively high afﬁnity of human EGF at
endosomal pH, we are unable to reproduce the phenomena in
which increasing afﬁnity increases recycling (results not
shown).
FIGURE 7 Simulated sorting curves for the afﬁnity model, in which
heterodimerization alters the dissociation rate of EGF. (A) The dissociation
rate of EGF from heterodimers (koff,het) is increased to 2.5 min
1 and the
model input is varied from 100% EGF-EGFR complexes/0% heterodimers
(solid line), to 50% EGF-EGFR complexes/50% heterodimers (dot-dashed
line), to 0% EGF-EGFR complexes/100% heterodimers (dotted line). (B)
koff,het is decreased to 0.1 min
1, and model input is varied from 100% EGF-
EGFR complexes/0% heterodimers (solid line), to 50% EGF-EGFR
complexes/50% heterodimers (dot-dashed line), to 0% EGF-EGFR com-
plexes/100% heterodimers (dotted line).
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DISCUSSION
Elevated HER2 expression and its interactions with EGFR
family members have been demonstrated to be of great
importance in tumor progression (Hynes and Stern, 1994).
HER2 ampliﬁes the magnitude of EGFR signaling through
the recruitment of additional signaling molecules and also
increases the duration of EGFR signaling via the disruption
of the normal trafﬁcking and downregulation of the EGFR
(Karunagaran et al., 1996;Worthylake et al., 1999). Impaired
EGFR trafﬁcking has been linked to tumor formation in mice
and as such, we have chosen to concern ourselves with
processes involved in receptor downregulation, speciﬁcally,
endosomal sorting (Wells et al., 1990). Recent work has
quantitatively demonstrated the importance of endosomal
sorting in determining the distribution and downregulation
of EGFR (Hendriks et al., 2003a). Endosomal sorting
represents a critical regulatory point in EGFR trafﬁcking
by controlling the fraction of receptors and ligands that are
targeted for degradation. In this study, we have utilized
computational modeling techniques to gain insight into the
receptor interactions that govern the qualitative aspects of the
observed endosomal sorting outcomes.
From the experimental data, the parental cell line is clearly
operating in the regime where EGFR complex interaction
with ERCs dominates and mediates EGF degradation.
Secondly, over the experimentally accessible range of intra-
cellular EGF concentration we do not see the onset of ERC
saturation, as the slope of the sorting curve remains negative.
For HER2 clone 24H, however, the shallow positive slope
suggests the onset of ERC saturation. Thus, elevated HER2
expression appears to accelerate the onset of endosomal
sorting saturation.
To account for this result, we have expanded the ERC
sortingmodel to includeHER2 and investigated howdifferent
HER2 interactions affect the sorting process. Qualitatively,
our three models give us one of two possible results, with the
differences manifesting themselves at low intracellular EGF
concentrations. In the blockade and afﬁnity model (in which
heterodimerization decreases afﬁnity), recycling is increased
at the low intracellular EGF concentrations, where the
leftmost portion of the sorting curve is shifted upwards. The
increase in recycling with HER2 expression simply reﬂects
the fraction of EGF-EGFR complexes that are in heterodimers
and each individual heterodimer directly affects the fraction
of EGF recycled. The competition model, by contrast, is
a titration effect, where increased presence ofHER2 inside the
sorting endosome is unable to alter EGF recycling until its
quantity is on the same order of magnitude as the number of
ERCs. Consequently, we observe a result where there is no
difference at low intracellular EGF concentration for the
different levels of HER2 expression. As intracellular EGF
increases the curves begin to diverge and elevated HER2
expression expedites the point at which endosomal saturation
begins.
While the three models proposed are not mutually exclu-
sive, comparison with experimental results suggests that the
competitive mechanism is dominant. Experimental sorting
outcomes for varying HER2 expression levels (see in Fig. 3
a) converge at low intracellular EGF, qualitatively similar to
the competition model results (see Fig. 6 a). However, it is
possible that different mechanisms may dominate in
different cell types. Data from Worthylake and Wiley show
that increased HER2 expression shifted the entire sorting
curve upward (Worthylake et al., 1999). This may be
indicative of the blockade or afﬁnity models being dominant,
or it is possible that the sorting curves may still converge if
experiments were carried out at sufﬁciently low EGF
concentrations.
We remind the reader that the purpose of this work is not
to quantitatively ﬁt the data, but rather to understand how
various molecular-level interactions are translated into
qualitative trends in the experimental data. A number of
the model parameters are based upon estimates from other
cell types and may not necessarily be optimal choices to
reﬂect our experimental setup. Nonetheless, the qualitative
nature of the model results is quite robust, and is insensitive
to reasonable parameter variations. Further, the model
assumes a constant input ﬂux of receptors and ligands for
ease of interpretation. Experimentally, the internalization
ﬂux may not be constant since internalization rates have been
shown to be a function of the number of surface complexes
and vary with the surface expression levels of HER2 as well
(Hendriks et al., 2003a,b; Wiley et al., 1991). For these
reasons, a direct, quantitative comparison of the experimen-
tal and modeling results is not appropriate.
Our models contain several simpliﬁcations including the
fact that EGF-EGFR complex homodimerization is not
explicitly included. In the original ERC model the EGF-
EGFR complex is the functional unit in terms of interaction
within the endosome. Conceptually, this unit could be
thought of either as a single EGF-EGFR complex or an EGF-
EGFR homodimer with no effect on the sorting results.
When HER2 is added to the model it is best to conceptualize
the EGF-EGFR representation as a homodimer and the
process of heterodimerization with HER2 simply reﬂects
trading an EGF-EGFR complex for a HER2 within the
dimer. If one explicitly includes all possible EGFR-HER2
interactions the results are indistinguishable from those
presented here (results not shown). These simpliﬁcations
serve to simplify the computations and do not affect the
characteristic qualities of each model—the blockade and
afﬁnity models still show immediate inﬂuence from HER2
expression, while the competition model requires sufﬁcient
HER2 present before any effect is apparent.
If HER2 affects EGF recycling through a competitive
mechanism then, at ﬁrst glance, one would expect hetero-
dimerization to have no effect on the sorting process. As
such, the addition of monoclonal antibody 2C4 would be
predicted to have no effect on EGF sorting. However, Fig.
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3 b shows this is not the case. If one considers the trafﬁcking
process as a whole, we ﬁnd that this is still consistent with
HER2 acting via a competitive mechanism. As a side effect
from blocking heterodimerization, one would predict that
2C4 prevents the EGF-induced internalization of HER2
(Hendriks et al., 2003a,b). Thus, addition of 2C4 prevents
the internalization of HER2 into the endosomal sorting
compartment so that it is unable to compete with EGFR for
ERC interaction. Heterodimerization itself is not predicted to
have any effect on the sorting process; however, effects at the
level of internalization affect the sorting process by dictating
the receptor composition within endosomal compartments.
The hypothesis that HER2 is able to alter EGFR sorting
through a competitive mechanism suggests that there must
be some sequence similarity between the two receptors in the
carboxy-terminal domain regions interacting with the sorting
apparatus. The precise identity of the endosomal retention
component remains unknown at present, but evidence
suggests that SNX1 may play such a role (Kurten et al.,
1996; Zhong et al., 2002). SNX1 was identiﬁed via its
interaction with EGFR residues 943–957, and has been
shown to localize to endosomal compartments. Its inhibition
decreases the rate of ligand-induced EGFR degradation,
consistent with the behavior of ERCs in the ERC sorting
model (French and Lauffenburger, 1996; Kurten et al., 1996;
Zhong et al., 2002). EGFR residues 943–957 are known to
interact with SNX1 and share 80% identity with HER2
residues 951–965, suggesting that HER2 may also be able to
interact with SNX1.
Another candidate for relevant involvement in the sorting
process is c-Cbl. Overexpression of c-Cbl stimulates ligand-
induced EGFR degradation (Levkowitz et al., 1999, 1998).
Further, c-Cbl associates only with EGF-EGFR homo-
dimers, but not with EGF-EGFR/HER2 heterodimers,
HER2, HER3, or HER4 (Levkowitz et al., 1996; Muthu-
swamy et al., 1999). A current model has c-Cbl transiently
associating with kinase-active EGFR to mediate ubiquitina-
tion, with ubiquitin-tagged EGFR then exhibiting increased
afﬁnity for the sorting apparatus resulting in enhanced
degradation (Wiley and Burke, 2001). The fact that he-
terodimerization impedes this process is suggestive of a
blockade-type mechanism; however, based on our results its
role in generating the experimentally-observed sorting
outcomes is not obvious.
Our integrative systems approach toward EGFR trafﬁck-
ing has gained us interesting insight into the trafﬁcking
process as a whole, especially in the context of a hierarchy of
receptor trafﬁcking models (Hendriks et al., 2003a,b). The
sorting process is tightly regulated and its output (sorting
fraction) is heavily dependent on the composition of its input
(complexes vs. heterodimers). In the case of the EGFR-
HER2 system it appears that the highest level of control is
exerted at the surface since this determines the input into
the sorting compartment. It is at the surface where the
distribution of complexes and heterodimers is determined.
Increased formation of heterodimers results in a reduced rate
of EGF internalization in addition to an increase in the
fraction recycled toward the surface (Hendriks et al.,
2003a,b). These two processes work in concert to maintain
EGFR expression on the surface and presumably maintain
signaling through surface-activated signaling pathways, such
PLC-g and calpain, both involved in cell migration. Whether
or not the distribution of dimer species reshufﬂes once in-
side of internal compartments due to a different receptor
composition is unclear. The degree to which these internal
species participate in signaling once internalized is also in
need of further investigation. Because trafﬁcking is an
iterative process, however, we would still expect sorting to
play an important role in the dictating long-term behavior
after successive rounds of internalization and recycling.
APPENDIX
Endosomal sorting model equations
The following equations are used to simulate the various possible effects of
HER2 on the steady state endosomal sorting of EGF. The model is solved at
steady state for varying inputs of complexes (IR1L) and heterodimers
(IR1LR2). Each model (blockade, competition, or afﬁnity) is independently
simulated by changing the appropriate parameters as described in Model
Development.
Central vesicle
dðR1vÞ=dt ¼ koff;het3R1LR2Ev  kon3 Lv3R1v1 kon
3R1Lv1 ku:R1E3R1Ev1 koff;het3R1LR2v
 ðg1 ksvÞ3R1v;
dðR2vÞ=dt ¼ kc3R1v3R2v1 ku;R1R23R1R2v  kc
3R1Lv3R2v1 ku;R1LR23R1LR2v  kc;R2E
3R2v3Ev1 ku;R2E3R2Ev  kc3R1Ev
3R2v1 ku;R1R23ER1R2v  kc3R1LEv
3R2v1 ku;R1LR23ER1LR2v1 koff;het3R1LR2v
1 koff;het3ER1LR2v  ðg1 ksvÞ3R2R1v;
dðR1LvÞ=dt ¼ IR1L1 kon3 Lv3R1v  kon3R1Lv  kc;R1E
3R1Lv3Ev1 ku:R1E3R1LEv  kc3R1Lv
3R2v1 ku;R1LR23R1LR2v  kc3R1Lv
3R2Ev1 ku;R1LR23R1LR2Ev  ðg1 ksvÞ
3R1Lv;
dðR1LR2vÞ=dt ¼ IR1LR2  koff;het3R1LR2v1 kc3R1Lv
3R2v  ku;R1LR23R1LR2v  kc;R1E;het
3R1LR2v3Ev1 ku:R1E3ER1LR2v
 kc;R2E;het3R1LR2v3Ev1 ku;R2E
3R1LR2Ev  ðg1 ksvÞ3R1LR2v;
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dðR1LEvÞ=dt¼kon3R1LEv1kon3R1Ev3Lv1kc;R1E
3R1Lv3Ev ku:R1E3R1LEv kc3R1LEv
3R2v1ku;R1LR23ER1LR2v ksv3R1LEv;
dðLvÞ=dt¼ 1=ðNav3ðVv1VtÞÞ3ðj=ð1 jÞ3ðIR1L
1 IR1LR2Þ kon3Lv3R1v1kon3R1Lv1kon
3R1LEv kon3R1Ev3Lv1koff;het3R1LR2v
1koff;het3R1LR2Ev1koff;het3ER1LR2v ksv
3Lv3Vv3Nav11=k3ðkon3k3Lv3R1t
1kon3R1Lt1koff;het3R1LR2t kst3k3Lv
3Vt3NavÞ;
dðR1EvÞ=dt¼ kon3R1LEv kon3R1Ev3Lv ku:R1E
3R1Ev1koff;het3ER1LR2v ksv3R1Ev;
dðR2EvÞ=dt¼ 1kc;R2E3R2v3Ev ku;R2E3R2Ev kc
3R1Lv3R2Ev1ku;R1LR23R1LR2Ev
1koff;het3R1LR2Ev ksv3R2Ev;
dðER1LR2vÞ=dt¼ kc3R1LEv3R2v ku;R1LR23ER1LR2v
1kc;R1E;het3R1LR2v3Ev ku:R1E
3ER1LR2v koff;het3ER1LR2v ksv
3ER1LR2v;
dðR1LR2EvÞ=dt¼koff;het3R1LR2Ev1kc;R2E;het3R1LR2v
3Ev ku;R2E3R1LR2Ev1kc3R1Lv
3R2Ev ku;R1LR23R1LR2Ev ksv
3R1LR2Ev;
dðEvÞ=dt¼kc;R1E3R1Lv3Ev1ku:R1E3R1LEv1ku:R1E
3R1Ev kc;R2E3R2v3Ev1ku;R2E3R2Ev
 kc;R2E;het3R1R2v3Ev1ku;R2E3R1R2Ev
1ku:R1E3ER1R2v kc;R1E;het3R1LR2v3Ev
1ku:R1E3ER1LR2v kc;R2E;het3R1LR2v3Ev
1ku;R2E3R1LR2Ev1ksv3ðR1LEv1R1Ev
1R2Ev1ER1R2v1R1R2Ev123ER1R2Ev
1R1LR2Ev1ER1LR2vÞ;
Vesicle tubule compartment
dðR1tÞ=dt¼kon3k3Lv3R1t1koff3R1Lt1koff;het
3R1LR2t1g3R1v kst3R1t;
dðR2tÞ=dt¼kc3R1Lt3R2t1ku;R1LR23R1LR2t1koff;het
3R1LR2t1g3R2v kst3R2t;
dðR1LtÞ=dt¼ 1kon3k3Lv3R1t koff3R1Lt kc
3R1Lt3R2t1ku;R1LR23R1LR2t1g
3R1Lv kst3R1Lt;
dðR1LR2tÞ=dt¼koff;het3R1LR2t1kc3R1Lt3R2t
 ku;R1LR23R1LR2t1g3R1LR2v kst
3R1LR2t;
Degradation compartment
dðR1dÞ=dt¼ ksv3ðR1v1R1Ev1R1Lv1R1LEv1R1R2v
1R1LR2v1ER1R2v1R1R2Ev1ER1R2Ev
1ER1LR2v1R1LR2EvÞ kh3R1d;
dðR2dÞ=dt¼ ksv3ðR2v1R1R2v1R1LR2v1R2Ev
1ER1R2v1R1R2Ev1ER1R2Ev
1ER1LR2v1R1LR2EvÞ kh3R2d;
dðLdÞ=dt¼ 1=ðNav3VdÞ3ðksv3Lv3Vv3Nav1ksv
3ðR1Lv1R1LEv1R1LR2v1ER1LR2v
1R1LR2EvÞ kh3Ld3Vd3NavÞ;
Recycling compartment
dðR1rÞ=dt¼ kst3ðR1t1R1Lt1R1R2t1R1LR2tÞ
 kx3R1r;
dðR2rÞ=dt¼ kst3ðR2t1R1R2t1R1LR2tÞ kx3R2r;
dðLrÞ=dt¼ 1=ðNav3VrÞ3ðkst3Lv3k3Vt3Nav1kst
3ðR1Lt1R1LR2tÞ kx3Lr3Vr3NavÞ:
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